1. Home
  2. CTS vs IVA Comparison

CTS vs IVA Comparison

Compare CTS & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$45.79

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.99

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTS
IVA
Founded
1896
2011
Country
United States
France
Employees
N/A
84
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CTS
IVA
Price
$45.79
$5.99
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$16.20
AVG Volume (30 Days)
202.0K
315.6K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
0.34%
N/A
EPS Growth
15.87
N/A
EPS
2.19
N/A
Revenue
$541,318,000.00
N/A
Revenue This Year
$5.55
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
$21.37
N/A
Revenue Growth
4.95
N/A
52 Week Low
$34.02
$2.70
52 Week High
$59.66
$7.98

Technical Indicators

Market Signals
Indicator
CTS
IVA
Relative Strength Index (RSI) 29.34 43.83
Support Level $40.41 $5.79
Resistance Level $59.66 $6.48
Average True Range (ATR) 1.62 0.30
MACD -0.86 -0.05
Stochastic Oscillator 3.90 9.70

Price Performance

Historical Comparison
CTS
IVA

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: